|Bid||113.35 x 1200|
|Ask||113.38 x 800|
|Day's Range||113.10 - 115.54|
|52 Week Range||62.94 - 121.06|
|PE Ratio (TTM)||N/A|
|YTD Daily Total Return||20.62%|
|Beta (5Y Monthly)||1.36|
|Expense Ratio (net)||0.35%|
The popularity of the sector continues with 57 new companies on tap to go public Continue reading...
GERM offers investors exposure to established providers and ‘unsung heroes’ of biotech and life sciences Continue reading...
Given the amount of attention paid to Covid-19 treatments and vaccines, it would be easy to assume that all of the good news was already reflected in biotech stocks. That’s not quite the case.